Clinical Trial Update: The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease [Phase 2]

View source ↗

Summary

Completed phase 2 trial assessing the effects of aplindore on signs and symptoms of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Aplindore (aplindore)

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Early Stage Parkinson's Disease | Phase 2 | Status: COMPLETED